Terms: = Germ cell tumor AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
41 results:
1. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
Zhang W; Zhang L; Dong H; Peng H
Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
3. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
4. Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation.
Hou W; Cai J; Shen P; Zhang S; Xiao S; You P; Tong Y; Li K; Qi Z; Luo H
Cancer Med; 2023 Dec; 12(24):22170-22184. PubMed ID: 38093622
[TBL] [Abstract] [Full Text] [Related]
5. The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay.
Doghish AS; Moustafa HAM; Elballal MS; Sallam AM; El-Dakroury WA; Abdel Mageed SS; Elesawy AE; Abdelmaksoud NM; Shahin RK; Midan HM; Elrebehy MA; Elazazy O; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Abulsoud AI
Pathol Res Pract; 2023 Aug; 248():154611. PubMed ID: 37315401
[TBL] [Abstract] [Full Text] [Related]
6. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Ofek P; Yeini E; Arad G; Danilevsky A; Pozzi S; Luna CB; Dangoor SI; Grossman R; Ram Z; Shomron N; Brem H; Hyde TM; Geiger T; Satchi-Fainaro R
Int J Cancer; 2023 Aug; 153(3):654-668. PubMed ID: 37141410
[TBL] [Abstract] [Full Text] [Related]
7. MAPK9 is Correlated with a Poor Prognosis and tumor Progression in Glioma.
Yang X; Jia Q; Liu X; Wu W; Han Y; Zou Z; Li M; Fan D; Song J; Chen L
Front Biosci (Landmark Ed); 2023 Mar; 28(3):63. PubMed ID: 37005756
[TBL] [Abstract] [Full Text] [Related]
8. Proposing Specific Neuronal Epithelial-to-Mesenchymal Transition Genes as an Ancillary Tool for Differential diagnosis among Pulmonary Neuroendocrine Neoplasms.
Prieto TG; Baldavira CM; Machado-Rugolo J; Olivieri EHR; da Silva ECA; Ab' Saber AM; Takagaki TY; Capelozzi VL
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553576
[TBL] [Abstract] [Full Text] [Related]
9. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
Front Immunol; 2022; 13():919145. PubMed ID: 36211371
[TBL] [Abstract] [Full Text] [Related]
10. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract] [Full Text] [Related]
11. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract] [Full Text] [Related]
12. Transcription factor YY1 contributes to human melanoma cell growth through modulating the p53 signalling pathway.
Zhou S; Li P; Qin L; Huang S; Dang N
Exp Dermatol; 2022 Oct; 31(10):1563-1578. PubMed ID: 35730240
[TBL] [Abstract] [Full Text] [Related]
13. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract] [Full Text] [Related]
15. Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.
Liu Y; Guo G; Lu Y; Chen X; Zhu L; Zhao L; Li C; Zhang Z; Jin X; Dong J; Yang X; Huang Q
Clin Transl Oncol; 2022 May; 24(5):816-828. PubMed ID: 34741724
[TBL] [Abstract] [Full Text] [Related]
16. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract] [Full Text] [Related]
17. Molecular monitoring of glioblastoma's immunogenicity using a combination of Raman spectroscopy and chemometrics.
Robert C; Tsiampali J; Fraser-Miller SJ; Neumann S; Maciaczyk D; Young SL; Maciaczyk J; Gordon KC
Spectrochim Acta A Mol Biomol Spectrosc; 2021 May; 252():119534. PubMed ID: 33588367
[TBL] [Abstract] [Full Text] [Related]
18. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
[TBL] [Abstract] [Full Text] [Related]
19. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
[TBL] [Abstract] [Full Text] [Related]
[Next]